(lp0
S'The Ironwood Pharmaceuticals, Inc.  Receives Outperform Rating from ... Petro Global News 24 - Jan 31, 2017 Several other equities research analysts also recently weighed in on the stock. Wedbush reiterated a neutral rating and set a $13.00 target price on shares of Ironwood Pharmaceuticals in a research note on Thursday, January 26th. Zacks Investment&nbsp;...'
p1
aS"Ironwood Pharmaceuticals, Inc. : What's the Story? StockNewsJournal - 15 hours ago Ironwood Pharmaceuticals, Inc.  is an interesting player in the Healthcare space, with a focus on Drugs - Generic.Ironwood Pharmaceuticals, Inc.  Shares Sold by Guggenheim Capital LLC - The Cerbat GemSomewhat Critical Press Coverage Somewhat Unlikely to Affect Ironwood ... - Markets Daily"
p2
aS"Here's Why Ironwood Pharmaceuticals, Inc. Jumped 19.52% in May The motley Fool  - Jun 9, 2016 Ironwood is also working to get Linzess approved in markets around the world. During its report the company announced that its other marketing partners Astellas Pharma and AstraZeneca have already submitted the drug for approval in Japan and China,&nbsp;...Ironwood and Allergan Announce Supplemental New Drug Application for 72 mcg ... - PR Newswire "
p3
aS'Ironwood Pharmaceuticals Appoints Dr. Christopher Wright as Senior Vice ... Yahoo Finance - Apr 6, 2017 Ironwood Pharmaceuticals, Inc. , a commercial biotechnology company, today announced the appointment of Christopher Wright, M.D.'
p4
aS"Featured Stock Overview: Ironwood Pharmaceuticals, Inc.  HugoPress - Apr 12, 2017 Barclays Maintains Ironwood Pharmaceuticals, Inc. 's stock to Equal-Weight with the price target of $12. This rating was issued on 8/05/16.Ironwood Pharmaceuticals, Inc.  Sees Significant Decrease in Short Interest - The Cerbat GemTechnical Clues For Ironwood Pharmaceuticals, Inc.  Investors - USA Commerce Daily"
p5
aS'Street View: Analyst Updates on Ironwood Pharmaceuticals, Inc. ? The Herald - Apr 14, 2017 Out of the 8 covering sell-side analysts giving share ratings for Ironwood Pharmaceuticals, Inc. , 4 have pegged the stock as a Strong Buy while 0 analysts have rated the stock a Buy.'
p6
aS'Ironwood Pharmaceuticals to Present at Cowen and Company 37 Business Wire  - Feb 28, 2017 CAMBRIDGE, Mass.----Ironwood Pharmaceuticals, Inc.  will present a corporate update at the Cowen and Company 37th Annual Health Care Conference on Monday, March 6, 2017 at 2:00 p.m. Eastern Time at the Boston&nbsp;...'
p7
aS'Ironwood Pharmaceuticals Inc.  Moves Higher on Volume Spike for March 08 Equities.com - Mar 8, 2017 Ironwood Pharmaceuticals Inc.  traded on unusually high volume on Mar. 08, as the stock gained 1.55% to close at $17.72.Ironwood Pharmaceuticals to Present at Barclays Global Healthcare Conference - Business Wire Buy or Sell? Average Brokerage Ratings on Mattel, Inc. , Ironwood ... - StockNewsJournal'
p8
aS'Stock Returns: Ironwood Pharmaceuticals Inc  is Beating Opko ... CML News - Mar 25, 2017 This is a snapshot to compare the stock returns for Ironwood Pharmaceuticals Inc  versus Opko Health Inc  .'
p9
aS'Option Market Alert: Ironwood Pharmaceuticals Inc Implied Price Swing Hits An ... CML News - Apr 14, 2017 No Risk Alert Here: Before we dive into any analysis we simply note that Ironwood Pharmaceuticals Inc  risk is neither elevated nor depressed.'
p10
a.